Patrik Forsell – General Manager, Takeda Denmark
Industry veteran Patrik Forsell oversees Takeda’s operations in Denmark. Here, Forsell talks through how sizeable shifts in the company’s global…
Tagged with Access
Linn Mandahl – General Manager, AbbVie Scandinavia
In a wide-ranging interview, AbbVie’s Linn Mandahl discusses how the reorganisation of Scandinavian operations back in 2018 has put the company back…
5 Denmark Pharma Country Managers Talk Market Access
Long established as a premier early launch country for innovative medicines within Europe, the Danish market access system has become more complicated…
Tore von Würden – Country Director Denmark & Iceland,…
Tore von Würden talks through Amgen Denmark’s focus areas of osteoporosis, cardiovascular disease, haematology, and oncology, where it hopes not…
Tashia Lentz – Managing Director, Biogen Denmark
Tashia Lentz of Biogen outlines what she sees as an increasingly tough market access environment for new treatments in Denmark and calls for greater…
Rodrigo Rodriguez – General Manager, Middle East Cluster,…
Rodrigo Rodriguez, general manager for Takeda’s Middle East cluster, discusses the company’s ambitions in the collective Saudi pharma market,…
Julie Enevold Brooker – Country Director, Janssen Denmark
Julie Enevold Brooker discusses what she sees as Janssen’s responsibility to help improve the Danish healthcare system beyond just bringing…
Flemming Sonne – CEO, Amgros, Denmark
Flemming Sonne of Denmark’s public hospital medicine procurement body Amgros outlines the scope and mission of the group, how its remit has…
Sanofi Genzyme EVP Bill Sibold Reflects on 30 Years of Rare…
Bill Sibold, Executive Vice President and Head of Sanofi Genzyme, highlights the achievements of the company’s Rare Humanitarian Program over the…
USA: Drug Innovations Are Delivering for Patients; We Need…
John M. O’Brien, recently appointed president and CEO of the US National Pharmaceutical Council, calls for innovation in benefit design reform to…
Denmark: Data Crucial To Innovative Access Agreements
Established in 2017, the Danish Medicines Council is the health technology assessment (HTA)-like body in Denmark which assesses the value for patients…
Italy’s Market Access Reform: A Watershed Moment?
In recent months, a profound transformation has been occurring right at the core of the Italian pharmaceutical industry as the most significant…
